Introduction: This bibliometric study systematically analyzes the research landscape of electroacupuncture (EA), focusing on its applications in pain relief and emotional regulation from 2014 to 2024. EA, a contemporary adaptation of traditional acupuncture, has gained significant attention for its potential therapeutic benefits in managing chronic pain and mood disorders.
Methods: Using the Web of Science Core Collection as the primary data source, we identified 537 articles related to EA's therapeutic effects. The analysis was conducted using bibliometric tools such as VOSviewer and CiteSpace to visualize publication trends, research hotspots, and collaborative networks.
Results: The study highlights a significant upward trend in research output, with a marked increase in publications from 2019 onwards. China emerged as the leading contributor, accounting for over 60% of the total research output, followed by the United States and South Korea. Key institutions, such as Zhejiang Chinese Medical University and Shanghai University of Traditional Chinese Medicine, have made substantial contributions, emphasizing the importance of traditional Chinese medicine in this research area. Major research themes include the modulation of neurotransmitter systems, the role of endogenous opioids, and the impact of EA on chronic pain and mood disorders. Collaborative networks between countries and institutions are mapped, revealing the centrality of Chinese and American research partnerships.
Discussion: This comprehensive analysis outlines the current state of EA research and identifies gaps and opportunities for future studies, particularly in understanding the mechanistic pathways of EA and its integration into mainstream medical practices. The findings provide a roadmap for enhancing the therapeutic applications of EA and underscore its potential in managing complex conditions involving both physical and emotional components.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891545 | PMC |
| http://dx.doi.org/10.3389/fneur.2025.1502657 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bibliometric and visual analysis in the field of electroacupuncture's analgesia and regulation on negative emotion from 2014 to 2024.
Front Neurol
February 2025
The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Introduction: This bibliometric study systematically analyzes the research landscape of electroacupuncture (EA), focusing on its applications in pain relief and emotional regulation from 2014 to 2024. EA, a contemporary adaptation of traditional acupuncture, has gained significant attention for its potential therapeutic benefits in managing chronic pain and mood disorders.
Methods: Using the Web of Science Core Collection as the primary data source, we identified 537 articles related to EA's therapeutic effects.
Secondary Meniere's Syndrome Following Excessive Noise Exposure.
Indian J Otolaryngol Head Neck Surg
February 2025
Christian Medical College, Vellore, Tamil Nadu India.
Background: The effects of noise on the vestibular and balance function are under-studied. Studies have demonstrated that like the cochlea, the otolith organs are also sensitive to sound but the exact mechanism is unclear. Both impulse and continuous noise exposure may damage the cochlear and/or vestibular organ and lead to the formation of endolymphatic hydrops.
View Article and Find Full Text PDFReal-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series.
BMC Ophthalmol
March 2025
Department of Ophthalmology, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK.
Background: Faricimab is a novel anti-vascular endothelial growth factor agent, used to treat patients with neovascular age-related macular degeneration (nAMD). This study assessed efficacy and safety of faricimab in previously treated eyes.
Methods: This retrospective study included previously treated nAMD patients who had received at least three faricimab injections.
Kidney Transplant Fast Track and Likelihood of Waitlisting and Transplant: A Nonrandomized Clinical Trial.
JAMA Intern Med
March 2025
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Importance: Kidney transplant (KT) is the optimal treatment for end-stage kidney disease (ESKD). The evaluation process for KT is lengthy, time-consuming, and burdensome, and racial and ethnic disparities persist.
Objective: To investigate the potential association of the Kidney Transplant Fast Track (KTFT) evaluation approach with the likelihood of waitlisting, KT, and associated disparities compared with standard care.
Implementing Accuracy, Completeness, and Traceability for Data Reliability.
JAMA Netw Open
March 2025
The Center for Observational Research, Amgen Inc, Thousand Oaks, California.
Importance: While it is well known that data quality underlies evidence validity, the measurement and impacts of data reliability are less well understood. The need has been highlighted in the 21st Century Cures Act of 2016 and US Food and Drug Administration (FDA) Real-World Evidence Program framework in 2018, draft guidance in 2021 and final guidance in 2024. Timely visibility into implementation may be provided by the Transforming Real-World Evidence With Unstructured and Structured Data to Advance Tailored Therapy (TRUST) study, a Verantos Inc-led FDA-funded demonstration project to explore data quality and inform regulatory decision-making.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!